Clinical Trial Update: Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria [NA]

View source ↗

Summary

Pilot trial evaluating switching HIV patients from tenofovir to raltegravir to resolve tenofovir-induced proteinuria; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Proteinuria

Drugs mentioned

• Raltegravir (raltegravir)

Snippet

Sponsor: Metropolis Medical | Conditions: HIV Infections, Proteinuria | NA | Status: COMPLETED | Results posted: 2015-05-12